0001641241-24-000002.txt : 20240229 0001641241-24-000002.hdr.sgml : 20240229 20240228185958 ACCESSION NUMBER: 0001641241-24-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240229 DATE AS OF CHANGE: 20240228 EFFECTIVENESS DATE: 20240229 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cyrus Biotechnology, Inc. CENTRAL INDEX KEY: 0001641241 ORGANIZATION NAME: IRS NUMBER: 471015686 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-506360 FILM NUMBER: 24697915 BUSINESS ADDRESS: STREET 1: 3005 1ST AVE STREET 2: SUITE 203 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 2062586561 MAIL ADDRESS: STREET 1: 3005 1ST AVE STREET 2: SUITE 203 CITY: SEATTLE STATE: WA ZIP: 98121 D 1 primary_doc.xml X0708 D LIVE 0001641241 Cyrus Biotechnology, Inc. 3005 1ST AVE SUITE 203 SEATTLE WA WASHINGTON 98121 2062586561 DELAWARE None None Corporation true Lucas Nivon 3005 1ST AVE SUITE 203 SEATTLE WA WASHINGTON 98121 Executive Officer Director Yifan Song 3005 1ST AVE SUITE 203 SEATTLE WA WASHINGTON 98121 Director Chad Waite 3005 1ST AVE SUITE 203 SEATTLE WA WASHINGTON 98121 Director Mark Benjamin 3005 1ST AVE SUITE 203 SEATTLE WA WASHINGTON 98121 Executive Officer Other Technology Decline to Disclose 06b false 2024-02-27 false true true true false 0 4000000 2694470 1305530 false 33 0 0 0 false Cyrus Biotechnology, Inc. Lucas Nivon Lucas Nivon Chief Executive Officer 2024-02-28